KCM
IONS icon

Kornitzer Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Kornitzer Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Hold
29,105
– – 0.05% 293
2026
Q1 		$2.19M Hold
29,105
– – 0.05% 292
2025
Q4 		$2.3M Buy
+29,105
New +$2.19M 0.05% 310

Other funds holding IONS

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Kornitzer Capital Management's IONS Position: Q2 2026 in Review

Kornitzer Capital Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 29,105 shares worth $2.31M. The position accounts for 0.05% of the portfolio, ranked #293.

Kornitzer Capital Management first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. 130 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Kornitzer Capital Management held 29,105 shares of Ionis Pharmaceuticals worth $2.31M as of Q2 2026.
  • Kornitzer Capital Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up 0.05% of Kornitzer Capital Management's portfolio in Q2 2026, its #293 holding.
  • Kornitzer Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 130 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.